Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate

Last updated: May 5, 2025
Sponsor: Shandong University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colon Polyps

Polyps

Treatment

Linked-color imaging endoscopy

Chromoendoscopy with indigo carmine solution spray

Clinical Study ID

NCT06961149
KYLL-202502-013-1
  • Ages 45-85
  • All Genders

Study Summary

Detection and removal of polyps during colonoscopy is crucial for the prevention of colorectal cancer. Indigo carmine spraying up to the colonic mucosa could probably increase the adenoma detection rate, but considering the long withdrawal time of the endoscope and the resulting increase in time and cost. Linked-color imaging (LCI) is a newly developed image-enhanced endoscopy technology. It relies on wave length optimization of three colors (red, green, and blue) to make the lesions appear fuller. LCI improves the visibility of colorectal adenomas and polyps and may increase the detection rate of lesions. In order to explore the clinical application value of Linked-color imaging endoscopy, we performed a prospective, randomized controlled trial to compare adenoma detection rate of Linked-color imaging endoscopy and indigo carmine chromoendoscopy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age between 45 and 85 years

  2. Patients with a history of colorectal adenoma

  3. Patients whose first-degree relatives have a history of colorectal cancer orcolorectal adenoma

  4. Patients with gastrointestinal symptoms (abdominal pain, bloody stool, chronicdiarrhea or constipation, Unexplained anemia or weight loss;

  5. Patients with positive Fecal Immunochemical Test

Exclusion

Exclusion Criteria:

  1. Patients with pregnancy, inflammatory bowel disease, familial adenomatosispolyposis, suspected CRC; intestinal obstruction, coagulopathy

  2. Patients with aspirin, clopidogrel or other anticoagulants/ antiplatelet drugsintake within 7 days

  3. Patents previous colorectal resection

  4. Patients with failed cecal intubation

  5. Patients with inadequate bowel preparation quality (BBPS≤5)

  6. Patients who refuse to participate or to provide informed consent

Study Design

Total Participants: 352
Treatment Group(s): 2
Primary Treatment: Linked-color imaging endoscopy
Phase:
Study Start date:
April 08, 2025
Estimated Completion Date:
April 01, 2026

Study Description

If patients scheduled for colonoscopy meet the inclusion criteria but not the exclusion criteria, participants will be recruited to the study and randomized to one of two groups. Group allocation was revealed to endoscopists upon confirmation of cecal intubation. participants in Group A (treatment group) will undergo colonoscopy with LCI. participants in Group B (control group) will undergo spraying indigo carmine solution during withdrawal process. Any lesions found during the procedure will be removed and sent for pathological examination. The investigator will record the participants' general information (such as gender, age, symptoms, body mass index,etc.), colonoscopy data (such as duration etc.), and lesion characteristics (such as location, morphology, histopathological classification, etc.). All data were analyzed according to the ITT analysis, and the PP analysis was performed for all outcomes. Continuous variables were presented as means ± standard deviation (SD), and compared using Independent Samples t test. Categorical variables were expressed as frequency counts (percentages) and analyzed using Pearson's chi-square test or the Fisher exact test. Statistical analyses were performed using SPSS 27.0. Statistical significance was defined as P < 0.05.

Connect with a study center

  • Qilu Hospital of Shandong University

    Jinan, Shandong 250012
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.